Compounds > dextropropoxyphene

Page last updated: 2024-08-21

dextropropoxyphene and fluoxetine

dextropropoxyphene has been researched along with fluoxetine in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (22.22)	18.2507
2000's	3 (33.33)	29.6817
2010's	4 (44.44)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
O'Brien, T	1
Fine, K; Hoffman, RS; Redd, JT; Stork, CM	1
Hajdú, P; Panyi, G; Tytgat, J; Ulens, C	1

Reviews

1 review(s) available for dextropropoxyphene and fluoxetine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

8 other study(ies) available for dextropropoxyphene and fluoxetine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Phototherapy burns and fluoxetine. The Australasian journal of dermatology, 1995, Volume: 36, Issue:2 Topics: Adult; Burns; Dextropropoxyphene; Female; Fluoxetine; Humans; Oxycodone; Psoriasis; Ultraviolet Therapy	1995
Propoxyphene-induced wide QRS complex dysrhythmia responsive to sodium bicarbonate--a case report. Journal of toxicology. Clinical toxicology, 1995, Volume: 33, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arrhythmias, Cardiac; Dextropropoxyphene; Drug Interactions; Electrocardiography; Female; Fluoxetine; Humans; Middle Aged; Sodium Bicarbonate	1995
Drug- and mutagenesis-induced changes in the selectivity filter of a cardiac two-pore background K+ channel. Cardiovascular research, 2003, Apr-01, Volume: 58, Issue:1 Topics: Amino Acid Motifs; Analgesics; Animals; Antidepressive Agents; Dextropropoxyphene; Female; Fluoxetine; Ion Channels; Mice; Mutagenesis, Site-Directed; Oocytes; Potassium Channels, Tandem Pore Domain; Sodium; Transcription, Genetic; Xenopus laevis	2003